News + Filings Holdings
|
Palo Alto Investors LP
> RVNC
| Date | Name | Ticker | Shares | Change | Value | Change | Price |
| 06/30/2023 | Revance Therapeutics, Inc. | RVNC | 5,228,609 | -41,600 | 132,336,094,000 | -37,417,338,000 | $25,310.00 |
| 03/31/2023 | Revance Therapeutics, Inc. | RVNC | 5,270,209 | -13,400 | 169,753,432,000 | 72,218,010,000 | $32,210.00 |
| 12/31/2022 | Revance Therapeutics, Inc. | RVNC | 5,283,609 | 878,570 | 97,535,422,000 | 97,416,486,000 | $18,460.00 |
| 09/30/2022 | Revance Therapeutics, Inc. | RVNC | 4,405,039 | 0 | 118,936,000 | 58,058,000 | $27.00 |
| 06/30/2022 | Revance Therapeutics, Inc. | RVNC | 4,405,039 | -10,650 | 60,878,000 | -25,228,000 | $13.82 |
| 03/31/2022 | Revance Therapeutics, Inc. | RVNC | 4,415,689 | 46,323 | 86,106,000 | 14,798,000 | $19.50 |
| 12/31/2021 | Revance Therapeutics, Inc. | RVNC | 4,369,366 | 1,167,500 | 71,308,000 | -17,896,000 | $16.32 |
| 09/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,201,866 | 0 | 89,204,000 | -5,699,000 | $27.86 |
| 06/30/2021 | Revance Therapeutics, Inc. | RVNC | 3,201,866 | 0 | 94,903,000 | 5,411,000 | $29.64 |
| 03/31/2021 | Revance Therapeutics, Inc. | RVNC | 3,201,866 | 528,553 | 89,492,000 | 13,730,000 | $27.95 |
| 12/31/2020 | Revance Therapeutics, Inc. | RVNC | 2,673,313 | 678,408 | 75,762,000 | 25,610,000 | $28.34 |
| 09/30/2020 | Revance Therapeutics, Inc. | RVNC | 1,994,905 | 290,533 | 50,152,000 | 8,531,000 | $25.14 |
| 06/30/2020 | Revance Therapeutics, Inc. | RVNC | 1,704,372 | 1,088,667 | 41,621,000 | 32,509,000 | $24.42 |
| 03/31/2020 | Revance Therapeutics, Inc. | RVNC | 615,705 | 527,115 | 9,112,000 | 7,674,000 | $14.80 |
| 12/31/2019 | Revance Therapeutics, Inc. | RVNC | 88,590 | 88,590 | 1,438,000 | 1,438,000 | $16.23 |
| 12/31/2014 | Revance Therapeutics, Inc. | RVNC | 0 | -80,369 | 0 | -1,554,000 | |
| 09/30/2014 | Revance Therapeutics, Inc. | RVNC | 80,369 | 80,369 | 1,554,000 | 1,554,000 | $19.34 |
| 06/30/2014 | Revance Therapeutics, Inc. | RVNC | 91,669 | 91,669 | 3,117,000 | 3,117,000 | $34.00 |
| 03/31/2014 | Revance Therapeutics, Inc. | RVNC | 91,669 | 91,669 | 2,888,000 | 2,888,000 | $31.50 |
| << Prev Next >> |
|